Natural history of changes in prostate specific antigen in early stage prostate cancer.
暂无分享,去创建一个
[1] H. Carter,et al. Mixed-effects regression models for studying the natural history of prostate disease. , 1994, Statistics in medicine.
[2] J. Cadeddu,et al. Relationship between changes in prostate-specific antigen and prognosis of prostate cancer. , 1993, Urology.
[3] T. Stamey,et al. Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.
[4] P. Carroll,et al. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression. , 1993, The Journal of urology.
[5] D. Chan,et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. , 1992, Cancer research.
[6] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[7] L. Holmberg,et al. High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.
[8] M. Gleave,et al. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. , 1992, Cancer research.
[9] S. Clejan,et al. Prostate specific antigen and prostatitis I. Effect of prostatitis on serum psa in the human and nonhuman primate , 1992, The Prostate.
[10] A. Whittemore,et al. Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence? , 1991, Journal of the National Cancer Institute.
[11] J. Adolfsson,et al. Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. , 1991, The Journal of urology.
[12] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[13] I. Thompson,et al. Expectant management of localized prostatic cancer , 1991, Cancer.
[14] D. Chan,et al. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer. , 1990, The Journal of urology.
[15] T. Stamey,et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.
[16] J. McNeal,et al. Pathology of benign prostatic hyperplasia. Insight into etiology. , 1990, The Urologic clinics of North America.
[17] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.
[18] S. Piantadosi,et al. Clinical evidence for and implications of the multistep development of prostate cancer. , 1990, The Journal of urology.
[19] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. , 1989, The Journal of urology.
[20] H. Adami,et al. NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.
[21] J. Oesterling,et al. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. , 1989, The Journal of urology.
[22] A. Partin,et al. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. , 1989, The Journal of urology.
[23] N. Juul,et al. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. , 1988, Scandinavian journal of urology and nephrology. Supplementum.
[24] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[25] T. Stamey,et al. PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.
[26] David Arenberg,et al. Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .
[27] P. Walsh,et al. The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.
[28] J. Meyer,et al. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling. , 1982, The Journal of urology.
[29] D. S. Coffey,et al. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. , 1982, Cancer research.